| 000 | 01801 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513113551.0 | ||
| 264 | 0 | _c19970417 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/endo.138.4.5047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzelei, J | |
| 245 | 0 | 0 |
_aAndrogen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. _h[electronic resource] |
| 260 |
_bEndocrinology _cApr 1997 |
||
| 300 |
_a1406-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAndrogen Antagonists |
| 650 | 0 | 4 |
_aAndrogens _xpharmacology |
| 650 | 0 | 4 |
_aAnilides _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
| 650 | 0 | 4 | _aCell Cycle |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aDihydrotestosterone _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlutamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMetribolone _xadministration & dosage |
| 650 | 0 | 4 |
_aNandrolone _xanalogs & derivatives |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aReceptors, Androgen _xgenetics |
| 650 | 0 | 4 |
_aTestosterone _xpharmacology |
| 650 | 0 | 4 | _aTestosterone Congeners |
| 650 | 0 | 4 | _aTosyl Compounds |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJimenez, J | |
| 700 | 1 | _aSoto, A M | |
| 700 | 1 | _aLuizzi, M F | |
| 700 | 1 | _aSonnenschein, C | |
| 773 | 0 |
_tEndocrinology _gvol. 138 _gno. 4 _gp. 1406-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.138.4.5047 _zAvailable from publisher's website |
| 999 |
_c9062310 _d9062310 |
||